GB0216412D0 - Chemical process - Google Patents

Chemical process

Info

Publication number
GB0216412D0
GB0216412D0 GBGB0216412.7A GB0216412A GB0216412D0 GB 0216412 D0 GB0216412 D0 GB 0216412D0 GB 0216412 A GB0216412 A GB 0216412A GB 0216412 D0 GB0216412 D0 GB 0216412D0
Authority
GB
United Kingdom
Prior art keywords
chemical process
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0216412.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to GBGB0216412.7A priority Critical patent/GB0216412D0/en
Publication of GB0216412D0 publication Critical patent/GB0216412D0/en
Priority to RU2005102395/04A priority patent/RU2326876C2/ru
Priority to PCT/GB2003/003041 priority patent/WO2004007473A1/fr
Priority to GB0500809A priority patent/GB2405637B/en
Priority to AU2003254450A priority patent/AU2003254450A1/en
Priority to AP2005003229A priority patent/AP2005003229A0/xx
Priority to ZA200501234A priority patent/ZA200501234B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
GBGB0216412.7A 2002-07-15 2002-07-15 Chemical process Ceased GB0216412D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0216412.7A GB0216412D0 (en) 2002-07-15 2002-07-15 Chemical process
RU2005102395/04A RU2326876C2 (ru) 2002-07-15 2003-07-15 Способ получения паклитаксела
PCT/GB2003/003041 WO2004007473A1 (fr) 2002-07-15 2003-07-15 Procede de preparation de paclitaxel
GB0500809A GB2405637B (en) 2002-07-15 2003-07-15 Process for preparing of Paclitaxel
AU2003254450A AU2003254450A1 (en) 2002-07-15 2003-07-15 Process for preparing of paclitaxel
AP2005003229A AP2005003229A0 (en) 2002-07-15 2003-07-15 Process for preparing of paclitaxel.
ZA200501234A ZA200501234B (en) 2002-07-15 2005-02-11 Process for preparing paclitaxel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0216412.7A GB0216412D0 (en) 2002-07-15 2002-07-15 Chemical process

Publications (1)

Publication Number Publication Date
GB0216412D0 true GB0216412D0 (en) 2002-08-21

Family

ID=9940483

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0216412.7A Ceased GB0216412D0 (en) 2002-07-15 2002-07-15 Chemical process
GB0500809A Expired - Fee Related GB2405637B (en) 2002-07-15 2003-07-15 Process for preparing of Paclitaxel

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0500809A Expired - Fee Related GB2405637B (en) 2002-07-15 2003-07-15 Process for preparing of Paclitaxel

Country Status (6)

Country Link
AP (1) AP2005003229A0 (fr)
AU (1) AU2003254450A1 (fr)
GB (2) GB0216412D0 (fr)
RU (1) RU2326876C2 (fr)
WO (1) WO2004007473A1 (fr)
ZA (1) ZA200501234B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1303077C (zh) * 2004-01-16 2007-03-07 桂林晖昂生化药业有限责任公司 合成紫杉烷的制备工艺
CN101274924B (zh) * 2007-03-27 2010-11-10 中国科学院大连化学物理研究所 一种制备紫杉醇及其衍生物的方法
US8791279B2 (en) * 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
CN104250235B (zh) * 2014-09-24 2016-10-05 江苏红豆杉药业有限公司 一种紫杉醇的制备方法
CN105418543A (zh) * 2015-12-01 2016-03-23 贵州大学 从南方红豆杉植物中提取巴卡亭iii对照品的方法
CN109438395A (zh) * 2018-12-25 2019-03-08 重庆市碚圣医药科技股份有限公司 一种紫杉醇中间体的合成方法及其产品

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017656A1 (fr) * 1996-10-24 1998-04-30 Institute Armand-Frappier Famille de taxanes canadensol, preparation semi-synthetique et usage therapeutique de ces derniers
US6020507A (en) * 1998-03-02 2000-02-01 Bristol-Myers Squibb Company Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile

Also Published As

Publication number Publication date
GB2405637A (en) 2005-03-09
AP2005003229A0 (en) 2005-03-31
AU2003254450A1 (en) 2004-02-02
ZA200501234B (en) 2006-10-25
RU2005102395A (ru) 2006-06-10
GB2405637B (en) 2006-02-22
WO2004007473A1 (fr) 2004-01-22
RU2326876C2 (ru) 2008-06-20
GB0500809D0 (en) 2005-02-23

Similar Documents

Publication Publication Date Title
TWI316058B (en) Chemical process
IL165286A0 (en) Chemical process
GB0324791D0 (en) Chemical process
GB0312896D0 (en) Chemical process
GB0320793D0 (en) Chemical process
GB0201505D0 (en) Process
GB0204607D0 (en) Process
GB0218041D0 (en) Chemical process
GB0205014D0 (en) Process
GB0202564D0 (en) Process
GB0229803D0 (en) Chemical process
GB0216412D0 (en) Chemical process
GB0201378D0 (en) Process
GB0210370D0 (en) Chemical process
GB0202563D0 (en) Process
GB0222833D0 (en) Chemical process
GB0203665D0 (en) Process
GB0302648D0 (en) Chemical process
GB0313920D0 (en) Chemical process
GB0221243D0 (en) Chemical process
GB0222619D0 (en) Process
GB0320795D0 (en) Chemical process
GB0313919D0 (en) Chemical process
HU0300278D0 (en) Chemical process
HU0300288D0 (en) Chemical process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)